The Allen Institute for Brain Science Completed the Brain Atlas
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
-
-
Biotechnology | CMO | Disease
Integrated DNA Technologies acquired Belgian manufacturer and established European operating base in Leuven, Belgium
On Sept. 18, 2006, Integrated DNA Technologies (IDT) announced the acquisition of RNA-TEC, based in Leuven, Belgium. The…
-
The OMRF celebrated it’s 60th anniversary
On Sept. 15, 2006, the Oklahoma Medical Research Foundation (OMRF) celebrated it’s 60th anniversary. More than 600 people…
-
National Cancer Institute researchers developed a new model for estimating the 5-year risk of melanoma
On Sept. 1, 2006, National Cancer Institute (NCI) researchers developed a new model for estimating the 5-year risk…
-
Sandia Center for Integrated Nanotechnologies facility (CINT) was dedicated
On Aug. 23, 2006, the Sandia Center for Integrated Nanotechnologies facility (CINT) was dedicated. Designed as a national…
-
National Cancer Institute researchers discovered unique pattern of gene activity that predict liver cancer spread
On Aug. 14, 2006, National Cancer Institute (NCI) researchers announced they had found a unique pattern of activity…
-
Corus Pharma was acquired by Gilead Sciences for $365 million
On Aug. 11, 2006, Gilead Sciences announced that it had completed its acquisition of Corus Pharma for $365…
-
The Frances Langford Heart Center opened its doors
On Aug. 1, 2006, the Frances Langford Heart Center opened its doors bringing open-heart surgery and interventional cardiology…
-
Sandia work on space shuttle showed live cells influence growth of nanostructures
On Jul. 20, 2006, Sandia and the University of New Mexico reported that experiments involving single-cell organisms in…
-
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
Alaska Airlines awarded E. Donnall Thomas Medal of Achievement Medal
On Jul. 18, 2006, the Fred Hutchinson Business Alliance announced that the E. Donnall Thomas Medal of Achievement…
-
Eli Lilly and Company’s Gemzar was approved for use in the treatment of women living with recurrent ovarian cancer
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved by the U.S. Food and Drug Administration (FDA) for…
-
Biotechnology | Diagnostics | NIH | Oncology
The National Cancer Institute scientists identified an inherited gene that strongly affects risk for the most common form of melanoma
On Jun. 29, 2006, researchers at the National Cancer Institute (NCI), part of the National Institutes of Health,…
-
ACIP recommends second dose of varicella vaccine for children
On Jun. 29, 2006, the Advisory Committee on Immunization Practices (ACIP) to the Centers for Disease Control and…
-
Johnsonﾠ &ﾠ Johnson acquired Pfizer Consumer Healthcare for $16.6 billion
On Jun. 27, 2006, Pfizer announced that it had reached a definitive agreement to sell its Pfizer Consumer…
-
Biotechnology | Diagnostics | NIH | Oncology
Gene expression profiling can accurately diagnose Burkitt’s lymphoma
On Jun. 7, 2006, gene profiling, a molecular technique that examines many genes simultaneously, can accurately distinguish between…
-
Washington BioEvolution, 2006
Washington BioEvolution illustrates life science companies and non-profit research organization in the State of Washington by the year…
-
Biotechnology | FDA | Vaccine
Zostavax was approved by the FDA to prevent shingles (herpes zoster) in individuals 60 years of age and older
On May 25, 2006, Zostavax, manufactured by Merck & Co. of Whitehouse Station, New Jersey, was approved by…
-
Personalized treatment trial for breast cancer was launched
On May 23, 2006, the Trial Assigning Individualized Options for Treatment (Rx), or TAILORx, was launched to examine…
-
Massey Cancer Center’s opened Goodwin Research Laboratory
On May 11, 2006, researchers at the Virginia Commonwealth University Massey Cancer Center began to n to move…
-
Dr. Stephen Prescott became president of the OMRF
On May 1, 2006, Dr. Stephen Prescott was named president of the Oklahoma Medical Research Foundation (OMRF). Prescott…
-
Biotechnology | Disease | NIH | Oncology | Therapeutics | Women's Health
Osteoporosis drug shown to be as effective as Tamoxifen in preventing invasive breast cancer
On Apr. 17, 2006, the National Cancer Institute (NCI) announced initial results of the Study of Tamoxifen and…
-
UW Madison alumni John and Tashia Morgridge pledged $50 million to support the Wisconsin Institutes of Discovery
On Apr. 3, 2006, UW Madison alumni John and Tashia Morgridge pledged $50 million – the largest individual…
-
Siteman Cancer Center was selected to be part of the National Comprehensive Cancer Network
On Mar. 22, 2006, the Siteman Cancer Center at Barnes-Jewish Hospital and Washington School of Medicine in St….
-
World Kidney Day was established
On Mar. 8, 2006, World Kidney Day, a joint initiative between the International Society of Nephrology (ISN) and…
-
VariZIG became available under an IND Expanded Access Protocol
On Feb. 24, 2006, the Advisory Committee on Immunization Practices (ACIP) was informed by the only U.S.-licensed manufacturer…
-
Groundbreaking was held for the North Carolina Research Campus
On Feb. 23, 2006, groundbreaking was held for the first building of the North Carolina Research Campus (NCRC),…
-
Sanofi Pasteur delivered H5N1 vaccine for U.S. government pandemic initiatives
On Feb. 6, 2006, Sanofi pasteur announced it had delivered more H5N1 vaccine to the U.S. government including…
-
Rotavirus vaccine, live, oral, pentavalent was licensed for use in infants ages 6 to 32 weeks
On Feb. 3, 2006, Rotavirus vaccine, live, oral, pentavalent (RotaTeq by Merck) was licensed for use in infants…
-
Biotechnology | Diagnostics | Medical Device | Medicine | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics
Dan L. Duncan contributed $100 million to the Baylor Cancer Center
On Jan. 31, 2006, Dan Duncan, founder of Enterprise Partners, an energy company in Houston, announced a donation…
-
Biotechnology | CDC | Diagnostics | Influenza | Vaccine
CDC stopped recommending adamantanes during 2005 season after high levels of influenza A (H3N2) virus resistance
On Jan. 17, 2006, the Centers for Disease Control and Prevention (CDC) announced that it had stopped recommending…
